Notice of Application - 2011
[Federal Register Volume 76, Number 75 (Tuesday, April 19, 2011)]
[Notices]
[Page 21916]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9370]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on December 14, 2010, Norac
Inc., 405 S. Motor Avenue, P.O. Box 577, Azusa, California 91702-3232,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the following basic
classes of controlled substances:
| Drug |
Schedule |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Methamphetamine (1105) |
II |
| Pentobarbital (2270) |
II |
| Nabilone (7379) |
II |
With regard to Gamma Hydroxybutyric Acid (2010),
Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the
company manufactures these controlled substances in bulk solely for
domestic distribution within the United States to customers engaged in
dosage-form manufacturing.
With regard to Nabilone (7379) only, the company presently
manufactures a small amount of this controlled substance in bulk solely
to conduct manufacturing process development internally within the
company. It is the company's intention that, when the manufacturing
process is refined to the point that its Nabilone bulk product is
available for commercial use, the company will export the controlled
substance in bulk solely to customers engaged in dosage-form
manufacturing outside the United States. The company is aware of the
requirement to obtain a DEA registration as an exporter to conduct this
activity.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than June 20, 2011.
Dated: April 11, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-9370 Filed 4-18-11; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |